Nomogram for Astigmatism Correction of KLEx
Recruiting now · Not applicable
Conditions studied: Astigmatism
In brief
The goal of this clinical trial is to learn if nomogram could promote treatment outcomes in astigmatism correction. The main question it aims to answer is: does the nomogram could promote treatment outcomes in astigmatism correction? If there is a comparison group: Researchers will compare non-nomogram adopted to see if the outcome acceptable. Participants will ask to complete 3-month follow-up of manifest refraction and visual acuity test.
Key facts
- Study ID
- NCT07605221
- Run by
- Tianjin Eye Hospital
- People needed
- 100
- Starts
- 2025-02-18
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-05-22
Who can join
Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- age ≥18 years; preoperative sphere -0.50 D to -10.00 D; preoperative cylinder -1.50 D to -5.00 D; stable refraction (±0.50 D) for 1 year; normal corneal topography; central corneal thickness >500 μm or predicted residual stromal bed >280 μm; intraocular pressure <21 mmHg
You may not qualify if…
- ocular or systematic disease
Where it is running
- Tianjin Eye Hospital — Tianjin, Tianjin Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.